mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-09 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-08 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-07 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-07 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-07 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-06 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
1e-05 |